Literature DB >> 2395647

Thermal denaturation profiles and gel mobility shift analysis of oligodeoxynucleotide triplexes.

R G Shea1, P Ng, N Bischofberger.   

Abstract

Oligodeoxypurine- and oligodeoxypyrimidine-containing strands were mixed under conditions conducive to the formation of triple stranded assemblies. The mixtures were characterized both by their UV absorbance change with increasing temperature and by their mobility in non-denaturing polyacrylamide gels. Duplexes 34 bp long containing 15 central purines on one strand and 15 complementary pyrimidines on the other strand yielded new melting transitions and showed different gel mobilities upon combination with oligopyrimidine 15-mers. The dependence of the thermal denaturation profiles on pH, salt concentration, GC content, strand orientation, base mismatches, and strand length was investigated.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2395647      PMCID: PMC331964          DOI: 10.1093/nar/18.16.4859

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  26 in total

1.  NMR studies of DNA (R+)n.(Y-)n.(Y+)n triple helices in solution: imino and amino proton markers of T.A.T and C.G.C+ base-triple formation.

Authors:  C de los Santos; M Rosen; D Patel
Journal:  Biochemistry       Date:  1989-09-05       Impact factor: 3.162

2.  Specificity in formation of triple-stranded nucleic acid helical complexes: studies with agarose-linked polyribonucleotide affinity columns.

Authors:  A G Letai; M A Palladino; E Fromm; V Rizzo; J R Fresco
Journal:  Biochemistry       Date:  1988-12-27       Impact factor: 3.162

3.  Triple-strand formation in the homopurine:homopyrimidine DNA oligonucleotides d(G-A)4 and d(T-C)4.

Authors:  P Rajagopal; J Feigon
Journal:  Nature       Date:  1989-06-22       Impact factor: 49.962

4.  Spectroscopic properties and helical stabilities of 25-nt parallel-stranded linear DNA duplexes.

Authors:  K Rippe; N B Ramsing; T M Jovin
Journal:  Biochemistry       Date:  1989-11-28       Impact factor: 3.162

Review 5.  The chemistry and biology of unusual DNA structures adopted by oligopurine.oligopyrimidine sequences.

Authors:  R D Wells; D A Collier; J C Hanvey; M Shimizu; F Wohlrab
Journal:  FASEB J       Date:  1988-11       Impact factor: 5.191

6.  Sequence-specific intercalating agents: intercalation at specific sequences on duplex DNA via major groove recognition by oligonucleotide-intercalator conjugates.

Authors:  J S Sun; J C François; T Montenay-Garestier; T Saison-Behmoaras; V Roig; N T Thuong; C Hélène
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

7.  Recognition of thymine adenine.base pairs by guanine in a pyrimidine triple helix motif.

Authors:  L C Griffin; P B Dervan
Journal:  Science       Date:  1989-09-01       Impact factor: 47.728

8.  Inhibition of DNA binding proteins by oligonucleotide-directed triple helix formation.

Authors:  L J Maher; B Wold; P B Dervan
Journal:  Science       Date:  1989-08-18       Impact factor: 47.728

9.  Inhibition of restriction endonuclease cleavage via triple helix formation by homopyrimidine oligonucleotides.

Authors:  J C François; T Saison-Behmoaras; N T Thuong; C Hélène
Journal:  Biochemistry       Date:  1989-12-12       Impact factor: 3.162

10.  Synthetic repeating sequence DNAs containing phosphorothioates: nuclease sensitivity and triplex formation.

Authors:  L J Latimer; K Hampel; J S Lee
Journal:  Nucleic Acids Res       Date:  1989-02-25       Impact factor: 16.971

View more
  11 in total

1.  Triplex formation by oligonucleotides containing novel deoxycytidine derivatives.

Authors:  C Y Huang; G Bi; P S Miller
Journal:  Nucleic Acids Res       Date:  1996-07-01       Impact factor: 16.971

2.  DNA protein interactions at the interferon-responsive promoter elements: potential for an H-DNA conformation.

Authors:  C Roy; B Lebleu
Journal:  Nucleic Acids Res       Date:  1991-02-11       Impact factor: 16.971

3.  Triple helix formation by purine-rich oligonucleotides targeted to the human dihydrofolate reductase promoter.

Authors:  S W Blume; J E Gee; K Shrestha; D M Miller
Journal:  Nucleic Acids Res       Date:  1992-04-11       Impact factor: 16.971

4.  Preparation and hybridization properties of oligonucleotides containing 1-alpha-D-arabinofuranosylthymine.

Authors:  A D Adams; C R Petrie; R B Meyer
Journal:  Nucleic Acids Res       Date:  1991-07-11       Impact factor: 16.971

5.  Quantitative experimental determination of primer-dimer formation risk by free-solution conjugate electrophoresis.

Authors:  Samantha M Desmarais; Thomas Leitner; Annelise E Barron
Journal:  Electrophoresis       Date:  2012-01-10       Impact factor: 3.535

6.  Thermodynamic and kinetic studies of the formation of triple helices between purine-rich deoxyribo-oligonucleotides and the promoter region of the human c-src proto-oncogene.

Authors:  P Aich; S Ritchie; K Bonham; J S Lee
Journal:  Nucleic Acids Res       Date:  1998-09-15       Impact factor: 16.971

7.  An efficient, sequence-specific method for crosslinking complementary oligonucleotides using binuclear platinum complexes.

Authors:  E S Gruff; L E Orgel
Journal:  Nucleic Acids Res       Date:  1991-12-25       Impact factor: 16.971

8.  Azole substituted oligonucleotides promote antiparallel triplex formation at non-homopurine duplex targets.

Authors:  R H Durland; T S Rao; V Bodepudi; D M Seth; K Jayaraman; G R Revankar
Journal:  Nucleic Acids Res       Date:  1995-02-25       Impact factor: 16.971

9.  6-Oxocytidine a novel protonated C-base analogue for stable triple helix formation.

Authors:  R Berressem; J W Engels
Journal:  Nucleic Acids Res       Date:  1995-09-11       Impact factor: 16.971

10.  Conformation effects of CpG methylation on single-stranded DNA oligonucleotides: analysis of the opioid peptide dynorphin-coding sequences.

Authors:  Malik Mumtaz Taqi; Sebastian K T S Wärmländer; Olga Yamskova; Fatemeh Madani; Igor Bazov; Jinghui Luo; Roman Zubarev; Dineke Verbeek; Astrid Gräslund; Georgy Bakalkin
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.